Viking Therapeutics's obesity/diabetes candidates and strong financials position it for success. Read here for an investment ...

Learn how the benefits of GLP-1s may be outweighed by the risks.

Novo Nordisk is in the lead, but not alone. Obesity doctors say they are gearing up for demand, predicted to be high. Some ...

"Real Housewives of New Jersey" star Dolores Catania candidly shared her experience with taking weight loss medication and ...

The two largest health insurers in Massachusetts are effectively telling the drug companies that they may seek a rapidly ...

Improving access and affordability could be transformative for public health, given that about 88% of Americans are ...

This is only a glimpse of the data available to CivicScience clients. Discover more data. It’s safe to say that GLP-1 ...

GLP-1 drugs alter taste perceptions, challenging food makers to adapt by enhancing umami flavours, balancing sweetness, and ...

Migraines are one of the world's most common neurological conditions, impacting nearly 15% of people globally. Despite this ...

Fibromyalgia patients taking GLP-1s have lower rates of opioid use, pain, fatigue, and malaise in a real-world patient data ...

Mouse livers were engineered via a one-time genome editing to secrete a GLP-1, cutting weight gain and improving glucose ...